TY - STD TI - Olver I. Cancer control—a global perspective. Eur J Cancer Care (Engl). 2017;26(1). https://doi.org/10.1111/ecc.12654. ID - ref1 ER - TY - STD TI - Knaul FM, Frenk J, Shulman L. For the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries. Closing the Cancer Divide: A Blueprint to Expand Access in Low and Middle Income Countries. Boston: Harvard Global Equity Initiative; 2011. ID - ref2 ER - TY - JOUR AU - Lima, L. G. AU - Souza, J. A. AU - Barrios, C. PY - 2013 DA - 2013// TI - Access to cancer medications in low- and middle-income countries JO - Nat Rev Clin Oncol VL - 10 UR - https://doi.org/10.1038/nrclinonc.2013.55 DO - 10.1038/nrclinonc.2013.55 ID - Lima2013 ER - TY - JOUR AU - Siddiqui, M. AU - Vincent, R. S. PY - 2012 DA - 2012// TI - The high cost of Cancer drugs and what we can do about it JO - Mayo Clin Proc VL - 87 UR - https://doi.org/10.1016/j.mayocp.2012.07.007 DO - 10.1016/j.mayocp.2012.07.007 ID - Siddiqui2012 ER - TY - BOOK AU - Mattke, S. AU - Haims, M. AU - Ayivi-Guedehossour, N. AU - Gillen, E. AU - Hunter, L. AU - Klautzer, L. PY - 2011 DA - 2011// TI - Improving access to medicines for non-communicable diseases in the developing world ID - Mattke2011 ER - TY - JOUR AU - Hogerzeil, H. V. AU - Liberman, J. AU - Wirtz, V. J. AU - Kishore, S. P. AU - Selvaraj, S. AU - Kiddell-Monroe, R. PY - 2013 DA - 2013// TI - Promotion of access to essential medicines for non-communicable diseases: practical implications of the un political declaration JO - Lancet. VL - 381 UR - https://doi.org/10.1016/S0140-6736(12)62128-X DO - 10.1016/S0140-6736(12)62128-X ID - Hogerzeil2013 ER - TY - STD TI - Ruff P, Al-Sukhun S, Blanchard C, Shulman LN. Access to Cancer therapeutics in low- and middle-income countries. Am Soc Clin Oncol Educ Book. 2016;35:58-65. https://doi.org/10.14694/EDBK_155975. ID - ref7 ER - TY - STD TI - World Health Organization. Cancer. 2018. https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed 15 Mar 2019. UR - https://www.who.int/news-room/fact-sheets/detail/cancer ID - ref8 ER - TY - STD TI - Stewart BW, Wild CP. World Cancer Report 2014. Lyon: International Agency for Research on Cancer, World Health Organization; 2014. ID - ref9 ER - TY - STD TI - Hanna TP, Kangolle AC. Cancer control in developing countries: using health data and health services research to measure and improve access, quality and efficiency. BMC Int Heal Hum Rights. 2010;10:24. ID - ref10 ER - TY - JOUR AU - Bazargani, Y. T. AU - Boer, A. AU - Schellens, J. H. M. AU - Leufkens, H. G. M. AU - Mantel-Teeuwisse, A. K. PY - 2014 DA - 2014// TI - Selection of oncology medicines in low-and middle-income countries JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdt514 DO - 10.1093/annonc/mdt514 ID - Bazargani2014 ER - TY - JOUR AU - Yohana, E. AU - Kamuhabwa, A. AU - Mujinja, P. PY - 2011 DA - 2011// TI - Availability and affordability of anticancer medicines at the ocean road Cancer Institute in Dar es salaam, Tanzania JO - East Africa J Public Heal VL - 8 ID - Yohana2011 ER - TY - STD TI - Sarwar MR, Iftikhar S, Saqib A. Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and highincome class patients in Pakistan. BMC Cancer. 2018;18:14. ID - ref13 ER - TY - STD TI - van Mourik MSM, Cameron A, Ewen M, Laing RO. Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data. BMC Cardiovasc Disord. 2010;10:25. ID - ref14 ER - TY - STD TI - Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240-9. https://doi.org/10.1016/S0140-6736(08)61762-6. ID - ref15 ER - TY - STD TI - Mendis S, Fukino K, Cameron A, Laing R, Filipe A, Khatib O, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ. 2007;85(4):279-88. ID - ref16 ER - TY - STD TI - Ewen M, Zweekhorst M, Regeer B, Laing R. Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases. PLoS One. 2017;12(2):e0171284. https://doi.org/10.1371/journal.pone.0171284. ID - ref17 ER - TY - STD TI - World Health Organization. Noncommunicable Diseases Country Profiles 2014. Geneva: World Health Organization; 2014. ID - ref18 ER - TY - JOUR AU - Reynoso-Noverón, N. AU - Meneses-García, A. AU - Erazo-Valle, A. AU - Escudero-de los Ríos, P. AU - Antonio Kuri-Morales, P. AU - Mohar-Betancourt, A. PY - 2016 DA - 2016// TI - Challenges in the development and implementation of the National Comprehensive Cancer Control Program in Mexico JO - Salud Publica Mex VL - 58 UR - https://doi.org/10.21149/spm.v58i2.7804 DO - 10.21149/spm.v58i2.7804 ID - Reynoso-Noverón2016 ER - TY - JOUR AU - Mohar-Betancourt, A. AU - Reynoso-Noverón, N. AU - Armas-Texta, D. AU - Gutiérrez-Delgado, C. AU - Torres-Domínguez, J. A. PY - 2017 DA - 2017// TI - Cancer trends in Mexico: essential data for the creation and follow-up of public policies JO - J Glob Oncol VL - 3 UR - https://doi.org/10.1200/JGO.2016.007476 DO - 10.1200/JGO.2016.007476 ID - Mohar-Betancourt2017 ER - TY - JOUR AU - Gómez Dantés, O. AU - Sesma, S. AU - Becerril, V. AU - Knaul, F. M. AU - Arreola, H. AU - Frenk, J. PY - 2011 DA - 2011// TI - Sistema de salud de México [the health system of Mexico] JO - Salud Publica Mex VL - 53 ID - Gómez Dantés2011 ER - TY - JOUR AU - Verastegui, E. AU - Mohar, A. PY - 2010 DA - 2010// TI - Colorectal cancer in Mexico: should a middle income country invest in screening or in treatment? JO - Eur J Health Econ VL - 10 UR - https://doi.org/10.1007/s10198-009-0190-1 DO - 10.1007/s10198-009-0190-1 ID - Verastegui2010 ER - TY - JOUR AU - Pérez-Cuevas, R. AU - Doubova, S. V. AU - Zapata-Tarres, M. AU - Flores-Hernández, S. AU - Frazier, L. AU - Rodríguez-Galindo, C. PY - 2013 DA - 2013// TI - Scaling up cancer care for children without medical insurance in developing countries: the case of Mexico JO - Pediatr Blood Cancer VL - 60 UR - https://doi.org/10.1002/pbc.24265 DO - 10.1002/pbc.24265 ID - Pérez-Cuevas2013 ER - TY - STD TI - Cervantes CAD, Botero MA. Average years of life lost due to breast and cervical cancer and the association with the marginalization index in Mexico in 2000 and 2010. Cad Saude Publica. 2014;30(5):1093-102. ID - ref24 ER - TY - STD TI - González-Robledo MC, Wong R, Ornelas HA, Knaul FM. Costs of breast cancer care in Mexico: analysis of two insurance coverage scenarios. Ecancermedicalscience. 2015;28;9:587. https://doi.org/10.3332/ecancer.2015.587. ID - ref25 ER - TY - STD TI - World Health Organization, Health Action International. Measuring medicine prices, availability, affordability and price components. 2nd ed. Switzerland: World Health Organization; 2008. p. 293. ID - ref26 ER - TY - STD TI - Gómez-Dantés H, Fullman N, Lamadrid-Figueroa H, Cahuana-Hurtado L, Darney B, Avila-Burgos L, et al. Dissonant health transition in the states of Mexico, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2016;388(10058):2386-402. https://doi.org/10.1016/S0140-6736(16)31773-1. ID - ref27 ER - TY - STD TI - Consejo Nacional de Población. Índice de marginación por entidad federativa y municipio 2015. https://www.gob.mx/conapo/documentos/indice-de-marginacion-por-entidad-federativa-y-municipio-2015. Accessed 15 Jan 2017. UR - https://www.gob.mx/conapo/documentos/indice-de-marginacion-por-entidad-federativa-y-municipio-2015 ID - ref28 ER - TY - STD TI - OECD. Measuring well-being in Mexican states. Paris: OECD Publishing; 2015. https://doi.org/10.1787/9789264246072-en. ID - ref29 ER - TY - BOOK PY - 2017 DA - 2017// TI - Deutschen Institut für Medizinsche Dokumentation und Information . Anatomisch-therapeutisch-chemische Klassifikation mit Tagesdosen ID - ref30 ER - TY - STD TI - Secretaría de Hacienda y Crédito Público. Salarios Mínimos 2017. http://www.sat.gob.mx/informacion_fiscal/tablas_indicadores/paginas/salarios_minimos.aspx. Accessed 20 Feb 2017. UR - http://www.sat.gob.mx/informacion_fiscal/tablas_indicadores/paginas/salarios_minimos.aspx ID - ref31 ER - TY - JOUR AU - Khatib, R. AU - McKee, M. AU - Shannon, H. AU - Chow, C. AU - Rangarajan, S. AU - Teo, K. PY - 2016 DA - 2016// TI - Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data JO - Lancet. VL - 387 UR - https://doi.org/10.1016/S0140-6736(15)00469-9 DO - 10.1016/S0140-6736(15)00469-9 ID - Khatib2016 ER - TY - STD TI - Management Sciences for Health. International Medical Products Price Guide. http://mshpriceguide.org/en/home/. Accessed 9 August 2017. UR - http://mshpriceguide.org/en/home/ ID - ref33 ER - TY - STD TI - Secretaria Executiva. Banco de precos de saúde. http://bps.saude.gov.br/login.jsf. Accessed 25 Sept 2017. UR - http://bps.saude.gov.br/login.jsf ID - ref34 ER - TY - STD TI - MINSALUD. Termómetro de precios de medicamentos. https://www.minsalud.gov.co/salud/MT/Paginas/termometro-de-precios.aspx. Accessed 25 Sept 2017. UR - https://www.minsalud.gov.co/salud/MT/Paginas/termometro-de-precios.aspx ID - ref35 ER - TY - STD TI - Ministerio de Salud. Observatorio Peruano de Productos Farmacéuticos. Sistema Nacional de Información de Precios http://observatorio.digemid.minsa.gob.pe/. Accessed 25 Sept 2017. UR - http://observatorio.digemid.minsa.gob.pe/ ID - ref36 ER - TY - STD TI - ChileCompra. Mercado Público - La plataforma de compras públicas y oportunidades de negocio del Estado de Chile. https://www.mercadopublico.cl/Home/BusquedaLicitacion. Accessed 25 Sept 2017. UR - https://www.mercadopublico.cl/Home/BusquedaLicitacion ID - ref37 ER - TY - JOUR AU - O’Shea Cuevas, G. J. PY - 2015 DA - 2015// TI - Seguro popular: hacia la cobertura del paciente oncológico [Seguro popular: towards cover for the oncology patient] JO - Gac Mex Oncol VL - 14 UR - https://doi.org/10.1016/j.gamo.2015.05.003 DO - 10.1016/j.gamo.2015.05.003 ID - O’Shea Cuevas2015 ER - TY - STD TI - Secretaría de Salud. Comisión Nacional de Protección Social en Salud. Anexo I 2017. http://www.seguro-popular.gob.mx/images/Contenidos/gestion/ANEXO_I_2017.pdf. Accessed 7 Jan 2017. UR - http://www.seguro-popular.gob.mx/images/Contenidos/gestion/ANEXO_I_2017.pdf ID - ref39 ER - TY - STD TI - World Health Assembly. Follow-up to the Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. Sixty-Sixth World Health Assemby. 2013. http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_R10-en.pdf?ua=1. Accessed 17 Aril 2018. UR - http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_R10-en.pdf?ua=1 ID - ref40 ER - TY - JOUR AU - Cherny, N. I. AU - Sullivan, R. AU - Torode, J. AU - Saar, M. AU - Eniu, A. PY - 2017 DA - 2017// TI - ESMO international consortium study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx521 DO - 10.1093/annonc/mdx521 ID - Cherny2017 ER - TY - STD TI - Servan-Mori E, Heredia-Pi I, Montañez-Hernandez J, Avila-Burgos L, Wirtz VJ. Access to medicines by Seguro popular beneficiaries: pending tasks towards universal health coverage. PLoS One. 2015;10(9):e0136823. https://doi.org/10.1371/journal.pone.0136823. ID - ref42 ER - TY - STD TI - Niëns LM, Cameron A, van de Poel E, Ewen M, Brouwer WBF, Laing R. Quantifying the impoverishing effects of purchasing medicines: a cross-country comparison of the affordability of medicines in the developing world. PLoS Med. 2010;7. ID - ref43 ER - TY - STD TI - Knaul FM, Arreola-Ornelas H, Méndez-Carniado O, Bryson-Cahn C, Barofsky J, Maguire R, et al. Evidence is good for your health system: policy reform to remedy catastrophic and impoverishing health spending in Mexico. Lancet. 2006;368:1828–41. ID - ref44 ER - TY - JOUR AU - Dorantes-Acosta, E. AU - Zapata-Tarrés, M. AU - Liliana Miranda-Lora, A. AU - Reyes-López, A. AU - Muñoz Hernández, O. AU - Cortés-Gallo, G. PY - 2012 DA - 2012// TI - Apoyo de organizaciones no gubernamentales a pacientes pediátricos con leucemia linfoblástica aguda afiliados al Seguro popular en México [support from nongovernmental organizations to pediatric patients with acute lymphoblastic leukemia affiliated with the Seguro popular in Mexico] JO - Bol Med Hosp Infant Mex VL - 69 ID - Dorantes-Acosta2012 ER - TY - STD TI - Moye-Holz D, van Dijk JP, Reijneveld SA, Hogerzeil HV. Policy approaches to improve availability and affordability of medicines in Mexico - an example of a middle income country. Global Health. 2017;13:53. ID - ref46 ER - TY - BOOK AU - O’she Cuevas, G. J. PY - 2016 DA - 2016// TI - LINEAMIENTOS para la adquisición de medicamentos asociados al Catálogo Universal de Servicios de Salud y al Fondo de Protección contra Gastos Catastróficos, por las entidades federativas con recursos transferidos por concepto de cuota social y de la aport PB - Diario Oficial de la Federación CY - Mexico ID - O’she Cuevas2016 ER - TY - JOUR AU - Gómez-Dantés, O. AU - Wirtz, V. J. AU - Reich, M. R. AU - Terrazas, P. AU - Ortiz, M. PY - 2012 DA - 2012// TI - A new entity for the negotiation of public procurement prices for patented medicines in Mexico JO - Bull World Health Organ VL - 90 UR - https://doi.org/10.2471/BLT.12.106633 DO - 10.2471/BLT.12.106633 ID - Gómez-Dantés2012 ER - TY - STD TI - Knaul FM, González-Pier E, Gómez-Dantés O, García-Junco D, Arreola-Ornelas H, Barraza-Lloréns M, et al. The quest for universal health coverage: achieving social protection for all in Mexico. Lancet. 2012;380(9849):1259-79. https://doi.org/10.1016/S0140-6736(12)61068-X. ID - ref49 ER - TY - STD TI - Wirtz VJ, Dreser AC. Alliance for Health Policy and Systems Research flagship report 2014. Medicines in Universal Health Care Coverage. Case Study of Seguro Popular in Mexico. AHPSR Flagsh Rep. 2014. Chapter 3, Annex 4: pages 11. ID - ref50 ER - TY - STD TI - Moïse P, Docteur E. Pharmaceutical Pricing and Reimbursement Policies in Mexico. Paris: OECD Publishing; 2007. ID - ref51 ER - TY - STD TI - Tobar F, Charreau J. Comparación internacional del precio de los medicamentos de alto costo. Argentina, Países del Cono Sur, España e Inglaterra [International comparison of the price of high-cost medicines. Argentina, Southern Cone Countries, Spain and England]. Buenos Aires: Instituto de Estudios sobre Políticas de Salud; 2011. ID - ref52 ER - TY - JOUR AU - Hernández-Ávila, J. E. AU - Palacio-Mejía, L. S. AU - González-González, L. AU - Morales-Carmona, E. AU - Espín-Arellano, L. I. AU - Fernández-Niño, J. A. PY - 2016 DA - 2016// TI - Utilization of hospital services for cancer care in Mexico JO - Salud Publica Mex VL - 58 UR - https://doi.org/10.21149/spm.v58i2.7783 DO - 10.21149/spm.v58i2.7783 ID - Hernández-Ávila2016 ER - TY - STD TI - IMS Health. Pharmaceutical market Mexico. Cham: IMS A.G.; 2011. ID - ref54 ER - TY - JOUR AU - Wirtz, V. J. AU - Hogerzeil, H. V. AU - Gray, A. L. AU - Bigdeli, M. AU - Joncheere, C. P. AU - Ewen, M. A. PY - 2017 DA - 2017// TI - Essential medicines for universal health coverage JO - Lancet. VL - 389 UR - https://doi.org/10.1016/S0140-6736(16)31599-9 DO - 10.1016/S0140-6736(16)31599-9 ID - Wirtz2017 ER -